Aug 8, 2022 08:00AM
Jul 18, 2022 07:31AM
Jul 18, 2022 07:30AM
May 9, 2022 08:00AM
May 3, 2022 08:01AM
May 3, 2022 08:00AM
Feb 28, 2022 08:00AM Sesen Bio Reports Fourth Quarter and Full-Year 2021 Financial Results and Anticipated Regulatory Path Forward for the Company’s Lead Product Candidate, Vicineum™
Jan 10, 2022 08:00AM
Dec 9, 2021 08:09AM
Dec 9, 2021 08:00AM
Nov 29, 2021 08:00AM
Nov 23, 2021 08:00AM
Nov 8, 2021 08:00AM
Nov 1, 2021 08:01AM Sesen Bio (SESN) Reports Productive Type A Meeting with the FFA
Nov 1, 2021 08:00AM
Oct 12, 2021 08:00AM
Aug 13, 2021 02:40PM
Aug 13, 2021 02:40PM
Aug 11, 2021 08:00AM
Aug 9, 2021 07:00AM
Aug 5, 2021 08:00AM Sesen Bio Announces Partnership with Eczacibasi Pharmaceuticals Marketing (EIP) for the Commercialization of Vicineum™ in Turkey
Aug 2, 2021 08:00AM
Jul 26, 2021 08:04AM
Jul 26, 2021 08:00AM
Jul 21, 2021 08:07AM
Jul 21, 2021 08:00AM
Jul 20, 2021 09:42AM
Jul 14, 2021 08:01AM Sesen Bio (SESN) Announces Productive Late-Cycle Meeting with the FDA for Vicineum
Jul 14, 2021 08:00AM
Jul 2, 2021 08:00AM
Jun 18, 2021 08:00AM
Jun 2, 2021 08:04AM
Jun 2, 2021 08:00AM
Jun 1, 2021 08:00AM
May 27, 2021 08:00AM Dr. Thomas Cannell, President and CEO of Sesen Bio, to Participate in Fireside Chat at the 2021 Jefferies Virtual Healthcare Conference
May 21, 2021 04:30PM
May 10, 2021 07:30AM
May 4, 2021 08:00AM
May 3, 2021 08:00AM
Apr 16, 2021 04:30PM
Apr 8, 2021 08:55AM
Apr 7, 2021 08:09AM Sesen Bio (SESN) Announces ISS and Glass Lewis Recommend “FOR” Proposal to Increase Authorized Shares
Apr 7, 2021 08:00AM
Mar 22, 2021 08:02AM
Mar 22, 2021 08:01AM
Mar 22, 2021 08:00AM
Mar 15, 2021 07:00AM
Mar 8, 2021 08:06AM
Mar 8, 2021 08:00AM Sesen Bio Submits Marketing Authorization Application to the European Medicines Agency for Vicineum™
Mar 2, 2021 08:00AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All